Stock Analysis on Net

Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.

Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.

Boeing Co., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

US$ in millions

Microsoft Excel
Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Accounts payable 11,238 11,034 11,364 12,267 11,864 11,616 11,964 11,143 10,936 10,274 10,200 9,793 9,575 8,779 9,261 10,151 11,450 12,410 12,928 14,479 13,700 14,963
Accrued liabilities 23,508 23,576 24,103 22,628 21,850 21,607 22,331 21,104 21,221 20,812 21,581 21,217 17,752 17,864 18,455 18,974 19,502 20,553 22,171 22,220 22,493 21,483
Advances and progress billings 59,407 61,114 60,333 57,931 58,151 58,972 56,328 55,924 55,310 54,498 53,081 53,177 52,066 52,458 52,980 51,269 50,738 50,908 50,488 51,974 53,367 52,883
Short-term debt and current portion of long-term debt 8,719 7,930 1,278 4,474 4,765 1,063 5,204 4,891 4,609 7,926 5,190 5,431 5,406 2,591 1,296 5,377 6,534 6,021 1,693 3,634 2,922 5,173
Liabilities held for sale 504
Current liabilities 103,376 103,654 97,078 97,300 96,630 93,258 95,827 93,062 92,076 93,510 90,052 89,618 84,799 81,692 81,992 85,771 88,224 89,892 87,280 92,307 92,482 94,502
Deferred income taxes 193 162 122 249 291 223 229 218 95 194 230 230 38 158 218 1,185 1,064 908 1,010 503 404 336
Accrued retiree health care 2,116 2,146 2,176 2,121 2,159 2,196 2,233 2,385 2,424 2,466 2,503 3,356 3,413 3,471 3,528 3,957 4,017 4,077 4,137 4,429 4,427 4,483
Accrued pension plan liability, net 5,803 5,909 5,997 6,097 6,248 6,400 6,516 5,713 5,855 5,998 6,141 7,951 8,335 8,719 9,104 11,435 13,519 13,968 14,408 15,343 15,663 15,962
Other long-term liabilities 2,324 2,260 2,318 2,314 2,212 2,546 2,332 2,239 2,158 2,198 2,211 2,250 1,891 1,879 1,750 1,722 1,571 1,477 1,486 2,907 2,821 3,398
Long-term debt, excluding current portion 44,604 45,688 52,586 53,176 53,162 46,877 47,103 47,381 47,659 47,465 51,811 51,788 51,794 55,150 56,806 57,042 57,025 57,554 61,890 57,325 58,457 33,754
Long-term liabilities 55,040 56,165 63,199 63,957 64,072 58,242 58,413 57,936 58,191 58,321 62,896 65,575 65,471 69,377 71,406 75,341 77,196 77,984 82,931 80,507 81,772 57,933
Total liabilities 158,416 159,819 160,277 161,257 160,702 151,500 154,240 150,998 150,267 151,831 152,948 155,193 150,270 151,069 153,398 161,112 165,420 167,876 170,211 172,814 174,254 152,435
Mandatory convertible preferred stock, 6.00% Series A, par value $1.00 6 6 6
Common stock, par value $5.00 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061 5,061
Additional paid-in capital 19,238 19,008 18,964 10,925 10,727 10,539 10,309 10,616 10,310 10,298 9,947 9,705 9,475 9,295 9,052 8,796 8,481 8,155 7,787 6,687 6,648 6,595
Treasury stock, at cost (31,603) (31,879) (32,386) (48,564) (48,841) (49,105) (49,549) (49,972) (50,181) (50,376) (50,814) (51,054) (51,319) (51,573) (51,861) (52,030) (52,223) (52,395) (52,641) (54,819) (54,829) (54,842)
Retained earnings 14,542 15,239 15,362 19,299 25,469 26,908 27,251 27,274 28,910 29,059 29,473 30,107 33,382 33,189 34,408 38,551 38,660 38,073 38,610 47,029 47,478 49,854
Accumulated other comprehensive loss (10,539) (10,760) (10,915) (10,273) (10,392) (10,412) (10,305) (9,708) (9,617) (9,550) (9,550) (11,518) (11,487) (11,370) (11,659) (14,818) (16,661) (16,952) (17,133) (15,779) (16,025) (16,333)
Shareholders’ deficit (3,295) (3,325) (3,908) (23,552) (17,976) (17,009) (17,233) (16,729) (15,517) (15,508) (15,883) (17,699) (14,888) (15,398) (14,999) (14,440) (16,682) (18,058) (18,316) (11,821) (11,667) (9,665)
Noncontrolling interests (1) (6) (10) (6) (7) 5 12 24 24 35 64 97 130 153 174 197 217 241 268 285 305
Total deficit (3,296) (3,325) (3,914) (23,562) (17,982) (17,016) (17,228) (16,717) (15,493) (15,484) (15,848) (17,635) (14,791) (15,268) (14,846) (14,266) (16,485) (17,841) (18,075) (11,553) (11,382) (9,360)
Total liabilities and deficit 155,120 156,494 156,363 137,695 142,720 134,484 137,012 134,281 134,774 136,347 137,100 137,558 135,479 135,801 138,552 146,846 148,935 150,035 152,136 161,261 162,872 143,075

Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


The financial data reflects various trends across the reported periods that provide insight into changes in liabilities, equity, and other balance sheet components.

Current Liabilities and Related Items
Accounts payable showed a declining trend from early 2020 through the end of 2021, reaching a low point, followed by moderate increases and some fluctuations thereafter up to mid-2025. Accrued liabilities generally decreased from 2020 through 2021 but experienced a recovery and then variability through 2024 and 2025. Advances and progress billings remained relatively stable with a slight upward tendency over the entire period, indicating steady contract advances. Short-term debt exhibited significant volatility, with sharp increases and decreases reflecting potential refinancing or liquidity management actions. Current liabilities overall declined from 2020 to late 2021, then fluctuated with a slight upward movement extending into 2025.
Long-term Liabilities and Debt
Long-term debt, excluding current portions, peaked sharply in mid-2020, then declined steadily through the end of 2023, followed by modest fluctuations thereafter. Other long-term liabilities remained mostly stable, with minor increases and decreases observed intermittently across the periods. Accrued pension liabilities showed a continuous descending trend until early 2023, after which moderate variability and some increases occurred, suggesting pension obligation adjustments. Accrued retiree health care liabilities gradually declined over time, indicating a gradual reduction in these obligations. Total long-term liabilities generally decreased from the 2020 highs through 2023 but saw some stabilization and slight upward revisions in later periods.
Total Liabilities and Deficit
Total liabilities peaked in mid-2020 and trended downward through late 2021, then experienced a generally steady state with some minor increases and decreases through 2025. Total deficit consistently worsened from early 2020 to late 2021, reflecting increasing negative equity components, but significantly improved starting in late 2024, showing a marked reduction in overall deficit that may relate to balance sheet restructuring or capital changes. Shareholders’ deficit largely mirrored the total deficit trends, highlighting sustained deficits that improved somewhat only in the last reported periods.
Equity and Capital Components
Common stock values remained constant throughout the periods, indicating no new common stock issuance or repurchase affecting par value. Additional paid-in capital showed gradual growth until 2024, followed by a sharp increase, potentially due to capital infusion or equity transactions. Treasury stock, reported as a negative value, decreased steadily in magnitude until late 2023, then reversed significantly in 2024, likely indicating changes in stock repurchase activities or accounting treatments. Retained earnings exhibited a downtrend from 2020 to 2024, with some stabilization or modest improvement thereafter, reflecting impacts on accumulated profits or losses.
Other Items
Deferred income taxes fluctuated without a clear long-term trend, showing both increases and decreases across the periods, which may reflect changing tax positions. Accumulated other comprehensive loss slightly improved in the earlier periods but deteriorated again in the latest quarters, indicating ongoing unrealized losses or adjustments affecting comprehensive income. Noncontrolling interests remained minor and declining, suggesting limited minority interest impact. Liabilities held for sale appeared only at the latest period, indicating potential disposal of certain assets or operations.

Overall, the data reveals a company managing a high level of liabilities with some deleveraging after mid-2020, coupled with ongoing challenges in equity positions reflected by substantial deficits. Fluctuations in short-term debt and treasury stock suggest active financial management and capital restructuring. The improvement in deficit measures in late periods may denote strategic efforts to strengthen the financial position going forward.